Literature DB >> 11062293

Release of glial tissue-specific proteins after acute stroke: A comparative analysis of serum concentrations of protein S-100B and glial fibrillary acidic protein.

M Herrmann1, P Vos, M T Wunderlich, C H de Bruijn, K J Lamers.   

Abstract

BACKGROUND AND
PURPOSE: This study was aimed at the comparative analysis of serum concentrations of glial fibrillary acidic protein (GFAP) and protein S-100B in patients with acute stroke.
METHODS: We investigated 32 patients with stroke symptoms consistent with cerebral ischemia in the anterior territory of vascular supply. Serial venous blood samples were taken after admission to the hospital and during the first 4 days after onset of stroke. Evaluation of lesion topography and volume of infarcted brain area was based on cranial CT data. The patients' clinical status was consecutively evaluated by the National Institutes of Health Stroke Scale (NIHSS) and the Barthel Index score at discharge from the hospital.
RESULTS: Protein S-100B and GFAP release was found to be significantly correlated (r=0.96; P:<0.001). The release of both biochemical markers was associated with the volume of brain lesions (S-100B: r=0.957, P:<0.0001; GFAP: r=0.955, P:<0.0001) and the neurological status at discharge from the hospital (S-100B: r=0.821, P:=0.0002; GFAP: r=0.717, P:=0.0003). The highest correlation between both S-100B and GFAP serum concentration and Barthel score was calculated at the last time of blood sampling, 4 days after stroke onset (S-100B: r=0.621, P:<0.001; GFAP: r=0.655, P:<0.001). The release of both astroglia derived proteins differed between different subtypes of stroke. GFAP was found to be a more sensitive marker of brain damage in patients with smaller lacunar lesions or minor strokes.
CONCLUSIONS: Our results indicate that postischemic release patterns of GFAP and S-100B protein may allow insight into the underlying pathophysiology of acute cerebral infarcts and may be used as a valuable tool of clinical stroke treatment.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11062293     DOI: 10.1161/01.str.31.11.2670

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  97 in total

1.  Glial neuronal ratio: a novel index for differentiating injury type in patients with severe traumatic brain injury.

Authors:  Stefania Mondello; Andreas Jeromin; Andras Buki; Ross Bullock; Endre Czeiter; Noemi Kovacs; Pal Barzo; Kara Schmid; Frank Tortella; Kevin K Wang; Ronald L Hayes
Journal:  J Neurotrauma       Date:  2012-04-10       Impact factor: 5.269

2.  Elevated levels of serum glial fibrillary acidic protein breakdown products in mild and moderate traumatic brain injury are associated with intracranial lesions and neurosurgical intervention.

Authors:  Linda Papa; Lawrence M Lewis; Jay L Falk; Zhiqun Zhang; Salvatore Silvestri; Philip Giordano; Gretchen M Brophy; Jason A Demery; Neha K Dixit; Ian Ferguson; Ming Cheng Liu; Jixiang Mo; Linnet Akinyi; Kara Schmid; Stefania Mondello; Claudia S Robertson; Frank C Tortella; Ronald L Hayes; Kevin K W Wang
Journal:  Ann Emerg Med       Date:  2011-11-08       Impact factor: 5.721

Review 3.  Predictive biomarkers of recovery in traumatic brain injury.

Authors:  Sabrina Giacoppo; Placido Bramanti; Marina Barresi; Debora Celi; Valeria Foti Cuzzola; Eleonora Palella; Silvia Marino
Journal:  Neurocrit Care       Date:  2012-06       Impact factor: 3.210

4.  Meningoencephalitis caused by Streptococcus pneumoniae: a diagnostic and therapeutic challenge. Diagnosis with diffusion-weighted MRI leading to treatment with corticosteroids.

Authors:  Philippe G Jorens; Paul M Parizel; Hendrik E Demey; Katrien Smets; Kris Jadoul; M M Verbeek; R A Wevers; Patrick Cras
Journal:  Neuroradiology       Date:  2005-09-07       Impact factor: 2.804

5.  [Postoperative delirium].

Authors:  S Pourhassan
Journal:  Chirurg       Date:  2006-09       Impact factor: 0.955

Review 6.  Candidate-based proteomics in the search for biomarkers of cardiovascular disease.

Authors:  Leigh Anderson
Journal:  J Physiol       Date:  2004-12-20       Impact factor: 5.182

7.  Plasma glial fibrillary acidic protein levels in a child with sickle cell disease and stroke.

Authors:  William J Savage; Allen D Everett; James F Casella
Journal:  Acta Haematol       Date:  2010-11-24       Impact factor: 2.195

8.  Clinical utility of serum levels of ubiquitin C-terminal hydrolase as a biomarker for severe traumatic brain injury.

Authors:  Stefania Mondello; Akinyi Linnet; Andras Buki; Steven Robicsek; Andrea Gabrielli; Joseph Tepas; Linda Papa; Gretchen M Brophy; Frank Tortella; Ronald L Hayes; Kevin K Wang
Journal:  Neurosurgery       Date:  2012-03       Impact factor: 4.654

9.  Protein biomarkers for traumatic and ischemic brain injury: from bench to bedside.

Authors:  Zhiqun Zhang; Stefania Mondello; Firas Kobeissy; Richard Rubenstein; Jackson Streeter; Ronald L Hayes; Kevin K W Wang
Journal:  Transl Stroke Res       Date:  2011-12-07       Impact factor: 6.829

10.  Astroglial proteins as diagnostic markers of acute intracerebral hemorrhage-pathophysiological background and clinical findings.

Authors:  Robert Brunkhorst; Waltraud Pfeilschifter; Christian Foerch
Journal:  Transl Stroke Res       Date:  2010-08-28       Impact factor: 6.829

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.